1. Catalogs
  2. Orpyx
  3. ENABLING YOU TO PREVENT DIABETIC FOOT ULCERS

ENABLING YOU TO PREVENT DIABETIC FOOT ULCERS

ENABLING YOU TO PREVENT DIABETIC FOOT ULCERS

Product catalog summary
Introduction
Diabetic peripheral neuropathy affects a significant portion of individuals with diabetes, leading to a loss of sensation in the feet. This condition increases the risk of developing foot ulcers, which can result in lower limb amputations.
Statistics
- 70% of people with diabetes develop peripheral neuropathy.
- 49% of foot ulcers lead to lower limb amputation.
- 49% of foot ulcers recur within 12 months, and 68% within 5 years.
Technology and Prevention
Custom insoles equipped with sensors monitor pressure, temperature, and activity. They provide real-time audiovisual alerts and offloading instructions when high pressure levels are detected. This sensory data helps guide care plans to maintain foot health.
Clinical Study
A multi-site clinical study demonstrated an 86% reduction in foot ulcer recurrence when Orpyx SI technology was used for at least 4.5 hours per day.
References
1. National Institute of Neurological Disorders and Stroke Peripheral Neuropathy Fact Sheet, Aug 2019.
2. Cavanagh PR, et al. Treatment for diabetic foot ulcers. Lancet 2005.
3. Armstrong DG, et al. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med 2017.
4. Abbot CA, et al. Innovative intelligent insole system study. Lancet Digital Health Oct. 2019.
Contact Information
Email: [email protected]
Phone: 1-855-996-7799
Website: www.orpyx.com
See more

Catalog excerpts

ENABLING YOU TO PREVENT DIABETIC FOOT ULCERS-1

ENABLING YOU TO PREVENT DIABETIC FOOT ULCERS 70% of people with diabetes develop diabetic peripheral neuropathy1, a condition that results in loss of feeling in the feet. 1 in 5 This inability to feel pain and respond to tissue damage can often lead to foot ulcers. foot ulcers will result in lower limb amputation2 49% of foot ulcers recur within 12 months and 68% within 5 years.3 A multi-site clinical study showed an 86% reduction in foot ulcer recurrence when Orpyx SI technology was worn at least 4.5 hours / day.4 Custom insoles incorporate sensors to monitor pressure, temperature and activity. Provides real-time audiovisual alerts and offloading instructions when sustained, high pressure levels occur. You and your health care provider use this sensory data to guide your care plan to keep your feet healthy. REFERENCES The National Institute of Neurological Disorders and Stroke Peripheral Neuropathy Fact Sheet, Aug 2019. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet 2005; 366(9498): 1725-35. David G. Armstrong, D.P.M., M.D., Ph.D., Andrew J.M. Boulton, M.D., and Sicco A. Bus, Ph.D. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med 2017;376:2367-75. 4 Abbot CA, et al. Innovative intelligent insole system reduces diabetic foot ulcer recurrence at plantar sites: a prospective, randomised, proof-of-concept study. Lancet Digital Health Oct. 2019; 1:e308-18. 1 2 3 All trademarks are the property of their respective owners.

 Open the catalog to page 1

All Orpyx catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.